Allergen advisory statement focus groups

The Food and Drug Administration is forecasting a contract to conduct focus groups aimed at deepening understanding of how consumers interpret and respond to allergen advisory statements, particularly from the perspective of allergen thresholds and risk-based messaging. This effort builds upon prior research and public input gathered during earlier focus groups and meetings on allergen advisory statements, seeking to inform more effective communication strategies that reflect consumer perceptions and preferences. The work will examine how different wording, labeling approaches, and risk assessments influence consumer behavior and decision-making around food products containing potential allergen traces. The project is classified under NAICS code 111110, indicating alignment with agricultural support activities, though the nature of the work is behavioral and communication research rather than farming or production. The FDA’s Office of Health Affairs, through its HFP Acquisition Liaison, is the primary point of contact, with the Contracting Officer role yet to be filled. The work is expected to be conducted in an unspecified location, with no set-aside designation or geographic restrictions noted. This initiative reflects the FDA’s ongoing commitment to improving food labeling transparency and consumer safety by grounding regulatory guidance in real-world consumer understanding.